TY - JOUR
T1 - Prognostic Impact of Node-Spreading Pattern in Surgically Treated Small-Cell Lung Cancer: A Multicentric Analysis
AU - Leuzzi, Giovanni
AU - Lococo, Filippo
AU - Alessandrini, Gabriele
AU - Sperduti, Isabella
AU - Spaggiari, Lorenzo
AU - Venuta, Federico
AU - Rendina, Erino A.
AU - Granone, Pierluigi
AU - Rapicetta, Cristian
AU - Zannini, Piero
AU - Di Rienzo, Gaetano
AU - Nicolosi, Maurizio
AU - Facciolo, Francesco
PY - 2017
Y1 - 2017
N2 - Objective: Although surgery in selected small-cell lung cancer (SCLC) patients has been proposed as a part of multimodality therapy, so far, the prognostic impact of node-spreading pattern has not been fully elucidated. To investigate this issue, a retrospective analysis was performed. Methods: From 01/1996 to 12/2012, clinico-pathological, surgical, and oncological features were retrospectively reviewed in a multicentric cohort of 154 surgically treated SCLC patients. A multivariate Cox proportional hazard model was developed using stepwise regression, in order to identify independent outcome predictors. Overall (OS), cancer-specific (CSS), and Relapse-free survival (RFS) were calculated by Kaplan-Meier method. Results: Overall, median OS, CSS, and RFS were 29 (95 % CI 18–39), 48 (95 % CI 19–78), and 22 (95 % CI 17–27) months, respectively. Lymphadenectomy was performed in 140 (90.9 %) patients (median number of harvested nodes: 11.5). Sixty-seven (47.9 %) pN0-cases experienced the best long-term survival (CSS: 71, RFS: 62 months; p < 0.0001). Among node-positive patients, no prognostic differences were found between pN1 and pN2 involvement (CSS: 22 vs. 15, and RFS: 14 vs. 10 months, respectively; p = 0.99). By splitting node-positive SCLC according to concurrent N1-invasion, N0N2-patients showed a worse CSS compared to those cases with combined N1N2-involvement (N0N2: 8 months vs. N1N2: 22 months; p = 0.04). On the other hand, the number of metastatic stations (p = 0.80) and the specific node-level (p = 0.85) did not affect CSS. At multivariate analysis, pN+ (HR: 3.05, 95 % CI 1.21–7.67, p = 0.02) and ratio between metastatic and resected lymph-nodes (RL, HR: 1.02, 95 % CI 1.00–1.04, p = 0.03) were independent predictors of CSS. Moreover, node-positive patients (HR: 3.60, 95 % CI 1.95–6.63, p < 0.0001) with tumor size ≥5 cm (HR: 1.85, 95 % CI 0.88–3.88, p = 0.10) experienced a worse RFS. Conclusions: In selected surgically treated SCLC, the long-term survival may be stratified according to the node-spreading pattern.
AB - Objective: Although surgery in selected small-cell lung cancer (SCLC) patients has been proposed as a part of multimodality therapy, so far, the prognostic impact of node-spreading pattern has not been fully elucidated. To investigate this issue, a retrospective analysis was performed. Methods: From 01/1996 to 12/2012, clinico-pathological, surgical, and oncological features were retrospectively reviewed in a multicentric cohort of 154 surgically treated SCLC patients. A multivariate Cox proportional hazard model was developed using stepwise regression, in order to identify independent outcome predictors. Overall (OS), cancer-specific (CSS), and Relapse-free survival (RFS) were calculated by Kaplan-Meier method. Results: Overall, median OS, CSS, and RFS were 29 (95 % CI 18–39), 48 (95 % CI 19–78), and 22 (95 % CI 17–27) months, respectively. Lymphadenectomy was performed in 140 (90.9 %) patients (median number of harvested nodes: 11.5). Sixty-seven (47.9 %) pN0-cases experienced the best long-term survival (CSS: 71, RFS: 62 months; p < 0.0001). Among node-positive patients, no prognostic differences were found between pN1 and pN2 involvement (CSS: 22 vs. 15, and RFS: 14 vs. 10 months, respectively; p = 0.99). By splitting node-positive SCLC according to concurrent N1-invasion, N0N2-patients showed a worse CSS compared to those cases with combined N1N2-involvement (N0N2: 8 months vs. N1N2: 22 months; p = 0.04). On the other hand, the number of metastatic stations (p = 0.80) and the specific node-level (p = 0.85) did not affect CSS. At multivariate analysis, pN+ (HR: 3.05, 95 % CI 1.21–7.67, p = 0.02) and ratio between metastatic and resected lymph-nodes (RL, HR: 1.02, 95 % CI 1.00–1.04, p = 0.03) were independent predictors of CSS. Moreover, node-positive patients (HR: 3.60, 95 % CI 1.95–6.63, p < 0.0001) with tumor size ≥5 cm (HR: 1.85, 95 % CI 0.88–3.88, p = 0.10) experienced a worse RFS. Conclusions: In selected surgically treated SCLC, the long-term survival may be stratified according to the node-spreading pattern.
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Carcinoma, Non-Small-Cell Lung
KW - Chemotherapy, Adjuvant
KW - Disease-Free Survival
KW - Female
KW - Humans
KW - Lung Neoplasms
KW - Lymph Node Excision
KW - Lymph Nodes
KW - Lymphadenectomy
KW - Lymphatic Metastasis
KW - Male
KW - Middle Aged
KW - Multimodality therapy
KW - Neoadjuvant Therapy
KW - Neoplasm Staging
KW - Node-spreading pattern
KW - Pneumonectomy
KW - Radiotherapy, Adjuvant
KW - Ratio
KW - Retrospective Studies
KW - Small-cell lung cancer
KW - Surgery
KW - Survival Rate
KW - Tumor Burden
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Carcinoma, Non-Small-Cell Lung
KW - Chemotherapy, Adjuvant
KW - Disease-Free Survival
KW - Female
KW - Humans
KW - Lung Neoplasms
KW - Lymph Node Excision
KW - Lymph Nodes
KW - Lymphadenectomy
KW - Lymphatic Metastasis
KW - Male
KW - Middle Aged
KW - Multimodality therapy
KW - Neoadjuvant Therapy
KW - Neoplasm Staging
KW - Node-spreading pattern
KW - Pneumonectomy
KW - Radiotherapy, Adjuvant
KW - Ratio
KW - Retrospective Studies
KW - Small-cell lung cancer
KW - Surgery
KW - Survival Rate
KW - Tumor Burden
UR - http://hdl.handle.net/10807/152032
U2 - 10.1007/s00408-016-9954-4
DO - 10.1007/s00408-016-9954-4
M3 - Article
SN - 0341-2040
VL - 195
SP - 107
EP - 114
JO - Lung
JF - Lung
ER -